Clorox reported $6.76B of revenue over the trailing twelve months, −3.7% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $6.76B (to Q3 2026). Net Income: $756M, trailing twelve months to Q3 2026. Free Cash Flow: $380M, trailing twelve months to Q3 2026. EPS: $6.16, trailing twelve months to Q3 2026.

CLXClorox

Consumer DefensiveUSD

$104.23

$86.1252 weeks$125.58

CLX as reported

Clorox reported $6.76B of revenue over the trailing twelve months, −3.7% on the year before. 9 reported series are charted on this page, each one as filed.

$6.76B

Revenue, trailing twelve months · to Q3 2026 · −3.7% against the twelve months before

Net Income: $756M
Net Income · +8.9% year on year · trailing twelve months to Q3 2026
Free Cash Flow: $380M
Free Cash Flow · −53% year on year · trailing twelve months to Q3 2026
EPS: $6.16
EPS · +11% year on year · trailing twelve months to Q3 2026

Every series Ryufin has for CLX, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$6.76B	−3.7%	Q3 2026
Net Income	$756M	+8.9%	Q3 2026
EPS	$6.16	+11%	Q3 2026
Gross Margin	44%	n/a	Q3 2026
Net Margin	11%	n/a	Q3 2026
ROE	−1269%	n/a	Q3 2026
ROA	14%	n/a	Q3 2026
Free Cash Flow	$380M	−53%	Q3 2026
P/E	16.9	n/a	today